MMEDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as MMEDV
MiniMed Group, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026
$17.79+0.30 (+1.72%)
Close on Oct 19, 2026
- Market cap
- $5.00B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2023 to 2026
Gross margin
54.2%
Operating margin
-6.1%
Net margin
-10.7%
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +14.3% | – | – | – | |
| Gross profit | +9.9% | – | – | – |
Returns and balance sheet
4 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2023 | FY2023 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -9.6% | |
| Current ratio | – | – | 1.92 | |
| Capex to revenue | – | – | 7.2% | |
| Diluted shares | – | – | 257M |
Cash use needs five years of cash flow figures
MiniMed does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-10.7%
×Asset turnover0.70×
×Equity multiplier1.27×
=Return on equity, FY2026-9.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | -10.7% | 0.70× | 1.27× | -9.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
2of 6 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero-$333.00M
- Cash generatingOperating cash flow above zero-$197.00M
- Return on assets improvedROA up on the prior year– → -7.9%
- Earnings backed by cashOperating cash flow above net income-$197.00M vs -$333.00M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.32 → 1.92
- No dilutionShare count did not rise253M → 257M
- Gross margin improvedGross margin up on the prior year56.28% → 54.16%
- More efficientAsset turnover rose– → 0.74